These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11719655)

  • 1. Prostate brachytherapy: comparison of dose distribution with different 125I source designs.
    Beyer DC; Puente F; Rogers KL; Gurgoze EM
    Radiology; 2001 Dec; 221(3):623-7. PubMed ID: 11719655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B; Pouliot J
    Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
    D'Souza WD; Thames HD; Kuban DA
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1540-8. PubMed ID: 15050335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
    Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose verification with Monte Carlo technique for prostate brachytherapy implants with (125)I sources.
    Zhang H; Baker C; McKinsey R; Meigooni A
    Med Dosim; 2005; 30(2):85-91. PubMed ID: 15922174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P; Thissen B; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal placement of radioisotopes for permanent prostate implants.
    Narayana V; Roberson PL; Winfield RJ; Kessler ML; McLaughlin PW
    Radiology; 1996 May; 199(2):457-60. PubMed ID: 8668794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of prostate implants based on postimplant treatment margin assessment.
    Mueller A; Wallner K; Merrick G; Courveau J; Sutlief S; Butler W; Gong L; Cho P
    Med Phys; 2002 Dec; 29(12):2782-7. PubMed ID: 12512711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.
    Zelefsky MJ; Cohen G; Zakian KL; Dyke J; Koutcher JA; Hricak H; Schwartz L; Zaider M
    Cancer J; 2000; 6(4):249-55. PubMed ID: 11038145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A detailed examination of the difference between planned and treated margins in 125I permanent prostate brachytherapy.
    Patel AB; Waterman FM; Dicker AP
    Brachytherapy; 2003; 2(4):223-8. PubMed ID: 15062130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose regions versus likelihood of cure after prostate brachytherapy.
    Wallner K; Merrick G; Sutlief S; True L; Butler W
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):170-4. PubMed ID: 15850918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Brachytherapy for prostate carcinoma].
    Yorozu A
    Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Apr; 65(2):87-91. PubMed ID: 15920966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
    Dicker AP; Lin CC; Leeper DB; Waterman FM
    Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
    Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources.
    Meigooni AS; Luerman CM; Sowards KT
    Med Phys; 2009 Apr; 36(4):1452-8. PubMed ID: 19472652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
    Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
    Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent implantation of 125I sources in the prostate: radical limits of simplicity.
    McLaughlin PW; Narayana V; Fields MT; Dworzanin ME; Winfield RJ; Roberson PL
    Radiology; 1999 Dec; 213(3):839-44. PubMed ID: 10580964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric characterization of radioactive sources employed in prostate cancer therapy.
    Zilio VO; Joneja OP; Popowski Y; Chawla R
    Brachytherapy; 2004; 3(4):201-14. PubMed ID: 15607152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.